| Application no. and date | 15184092.3 (espacenet) (Federated) (European Patent Register), 20120626 | | Patent/reg. no. and date | DK/EP 3034497, 20191218 | | Publication date | 20160622 | | Priority no. and date | US 201161501687 P, 20110627, US 201261635745 P, 20120419 | | EP pub. no. and date |
EP 3034497 20160622 | | Effective date | | | Applicant/owner | Parion Sciences, Inc., 2800 Meridian Parkway
Suite 195
Durham, NC 27713, US | | Applicant ref. no. | P72473DK01 | | Inventor | JOHNSON, Michael, R., c/o Parion Sciences, Inc.
2800 Meridian Parkway
Suite 195
Durham, North Carolina 27713, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/4965 (2006.01) , A61P 11/00 (2006.01) , C07D 239/48 (2006.01) | | Title | 3,5-DIAMINO-6-CHLOR-N-(N-(4-(4-(2-(HEXYL(2,3,4,5,6-PENTA-HYDROXYHEXYL)AMINO)ETHOXY)PHENYL)BUTYL) CARBAMIMIDOYL)PYRAZIN-2-CARBOXAMID | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
